Water Vapor Ablation for Prostate Cancer: Long-Term Registry

Part of paid clinical trials in San Antonio, Texas.

Sponsor
Francis Medical Inc.
Study ID
NCT07455058
Status
Recruiting

Conditions

Eligibility Criteria

Sex
MALE
Age
N/A - N/A
Healthy Volunteers
Not accepted

Interventions

  • Vanquish Therapy — DEVICE
    The Francis Medical, Inc. Vanquish Water Vapor Ablation Device ("Vanquish" or "Vanquish System") is a transurethral thermal water vapor ablation device. The Vanquish System is designed ablate prostate tissue, while minimizing side effects.

Study Details

The purpose of the registry is to evaluate real-world safety, efficacy, and patient reported outcomes among participants receiving Vanquish Water Vapor Ablation System therapy (Vanquish Therapy). This includes longitudinal assessment of patients who have received or will receive the therapy one or multiple times as part of routine clinical care and encompasses those who completed a company-sponsored Vanquish therapy study (as applicable).

Key Dates

Start date
Jun 5, 2026
Status verified
Feb 2026
Primary completion
Apr 30, 2041
Completion
Jul 31, 2041

Study Design

Enrollment
2,500 participants (estimated)

Arms

  • Arm: Vanquish Procedure Patients
    Patients that have completed or will complete a Vanquish therapy and plan to continue their routine clinical care.

Primary Outcome Measure

Primary Efficacy Outcome [ Time Frame: Through study completion, or up to 15 years. ]

Central Contacts

Locations (2)

FacilityCityStateZIPSite coordinators
The Urology Place, Inc.San AntonioTexas78240
Naveen Kella, MD
210-617-3670
Naveen Kella, MD (PRINCIPAL_INVESTIGATOR)
Savannah Eggerss, PA (SUB_INVESTIGATOR)
Urology of VirginiaVirginia BeachVirginia23462
Robert Given, MD
757-452-3461
Robert Given, MD (PRINCIPAL_INVESTIGATOR)

Find similar trials in San Antonio, TX

By condition

Related Studies